Atlas Trials

A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes

Clinical trial NCT07032688 · RECRUITING

Trial details

NCT number
NCT07032688
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2025-08-11
Primary completion
2027-03-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.